Highlights of 2020 ASCO Annual Meeting

This year the American Society of Clinical Oncology (ASCO) Annual Meeting was delivered in a new virtual format on May 29-31, 2020 with a record-breaking attendance of more than 42,700 participants from 138 countries. The scientific program comprised nearly 5,300 abstracts and more than 100 on-demand and broadcast sessions featuring more than 2,300 oral and poster presentations, a plenary session on the top five practice-changing studies, cancer-specific highlights sessions featuring the highest-impact studies in each area, and clinical cancer symposia. Here are highlig...

Далее...


The results of the research supported by the RakFond by Bulatov E.R.

Immunotherapy with genetically modified lymphocytes, such as CAR-T cells, is one of the most promising areas of modern basic and clinical oncology. A CAR-T cell is a T-lymphocyte in which a gene encoding a CAR (chimeric antigen receptor) has been introduced ex vivo. Simplifying the concept, one can say that a T cell is a soldier of the regular troops, and a CAR-T cell is the special forces for performing highly complex tasks. An extracellular domain of the CAR provides recognition of the target tumor antigen (e.g. CD19), and an intracellular domain activates the mechanisms ...

Далее...


Dear Friends and Colleagues! Today, on March 16, Professor Boris Afanasyev, member of the Foundation’s Scientific Advisory Board, Doctor of Medical Sciences, Honored Doctor of the Russian Federation, Director of the R.M. Gorbacheva Institute of Pediatric Oncology, Hematology, Oncology and Transplantology, founder of one of the first bone marrow transplant departments in the Russian Federation, suddenly passed away. His contribution to the oncology science is indisputable, he was an outstanding physician and the Teacher for many people. An amazing person, a unique ...

Далее...


RakFond Announces a New Competition of Research Projects in Radiation Therapy

Today, on World Cancer Day, the Foundation for Cancer Research Support opens applications submission to the competition of research projects in radiation therapy in oncology.

Далее...


NEWS OF THE XXIII RUSSIAN ONCOLOGY CONGRESS

  • онкоконгресс
В первый день XXIII Российского онкологического конгресса РакФонд и Российское общество клинической онкологии провели совместный мастер-класс, посвященный клиническим исследованиям в онкологии

Далее...


RAKFOND AND RUSSCO AWARD FOR THE BEST RESEARCH

Today, November 12, at the opening ceremony of the XXIII Russian Oncology Congress, the results of the selection of the best research presented at the session “Russian Research Results” were announced.

Далее...


NEWS OF THE ESMO 2019 CONGRESS: ONCOGYNECOLOGY AND BREAST CANCER TREATMENT

By Alexey Rumyantsev, MD, Department of Chemotherapy and Clinical Oncology, N.N. Blokhin National Medical Research Center of Oncology In September 2019, the annual congress of the European Society for Medical Oncology (ESMO) was held in Barcelona. This is the largest European conference in oncology, where the results of the studies, which could make an impact on clinical practice of cancer treatment in the very near future, were presented. During the first presidential symposium, the results of three large randomized trials on maintenance therapy with PARP inhibit...

Далее...


The 2019 Nobel Prize Laureates in Physiology or Medicine

  • нобелевская премия по медицине 2019
The announcement of the 2019 Nobel Prize laureates started on October 7, 2019. The 2019 Nobel Prize in Physiology or Medicine is awarded jointly to William G. Kaelin Jr, Sir Peter J. Ratcliffe and Gregg L. Semenza “for their discoveries of how cells sense and adapt to oxygen availability.” 

Далее...


ANNUAL CANCER PROGRESS REPORT ISSUED BY THE AMERICAN ASSOCIATION FOR CANCER RESEARCH

  • ДОКЛАД АМЕРИКАНСКОЙ АССОЦИАЦИИ ПО ИЗУЧЕНИЮ РАКА О ПРОГРЕССЕ В ОНКОЛОГИИ
This September, the American Association for Cancer Research (AACR) released its annual Cancer Progress Report, which highlights advances over the past year in the prevention, detection, diagnosis, and treatment of cancer. 

Далее...


ESMO CONGRESS

  • ESMO
The study by Alexey Rumyantsev, supported by the RUSSCO/RakFond grant, was cited at the ESMO Congress.

Далее...